About this Special Issue
Despite the progress achieved over the last two decades in the field of therapeutic immunosuppression, immune-mediated destruction of allograft (aka chronic rejection) remains among the first causes of late failure. A better understanding of the mechanisms involved first in allorecognition and then in generating graft damages and allograft fibrosis, appears as a mandatory step to design future innovative therapeutic strategies with the potential to improve long-term outcomes.
This Special Issue of Transplant International gathers the best international experts to propose a synthesis of the latest advances in transplant immunology in the field of chronic rejection immunopathology.
Important
As a Gold open-access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.
Please see the following pages for:
Publishing Fees
Author Guidelines
Keywords: allograft, immunosuppression, allorecognition, allograft fibrosis
